Risk Management

OMIC Digest Archives 2019

OMIC Digest: Vol. 29 | No. 1 | 2019

  • Feature: Dangers posed by systemic medications
  • Eye on OMIC: Dividend and rate news for 2020 and an industry outlook
  • Policy Issues: Limits of liability
  • Closed Claim Study: Other factors delay the diagnosis of Plaquenil toxicity
  • Risk Management Remedies: Tips to avoid medication errors and litigation
  • < click to view or download

OMIC Digest: Vol. 29 | No. 2 | 2019

  • Feature: Equipment and device issues in claims.
  • Eye on OMIC: Private equity partnerships, streamlined underwriting, and cyber enhancements
  • Policy Issues: Coverage when machines malfunction
  • Closed Claim Study: Equipment malfunction or improper set up of a surgical device?
  • Risk Reduction Strategies: Ensure safe use of equipment
  • < click to view or download
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

#1. Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $20 Million to our members through dividends.